Co-Diagnostics, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
CODX Over the counter 3840 co-dx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Co-Diagnostics, Inc.

Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs Dubai - Feb 9th, 2026 7:00 am
Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument - Feb 5th, 2026 7:00 am
Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification in Preparation for Manufacturing Upcoming PCR Platform - Feb 4th, 2026 7:00 am
Will Community Health's $450M Hospital Divestment Reduce Debt Burden? - Jan 22nd, 2026 7:38 am
Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships - Jan 12th, 2026 7:00 am
Co-Diagnostics announces 1-for-30 reverse stock split - Dec 31st, 2025 7:10 am
Co-Diagnostics Announces Reverse Stock Split - Dec 30th, 2025 7:00 am
Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies - Dec 29th, 2025 7:00 am
Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India - Dec 18th, 2025 7:00 am
Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Confirm Reactivity Against Flu A H3N2 Mutation - Dec 17th, 2025 7:00 am
Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025 - Dec 9th, 2025 7:00 am
Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India - Dec 8th, 2025 10:36 am
CoDiagnostics (CODX) Upgraded to Buy: Here's What You Should Know - Dec 2nd, 2025 10:00 am
Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health - Nov 20th, 2025 7:00 am
Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA - Nov 18th, 2025 7:00 am
Co-Diagnostics Inc (CODX) Q3 2025 Earnings Call Highlights: Strategic Ventures and Financial ... - Nov 13th, 2025 10:02 pm
Co-Diagnostics (CODX) Q3 2025 Earnings Transcript - Nov 13th, 2025 3:29 pm
Co-Diagnostics, Inc. (CODX) Reports Q3 Loss, Misses Revenue Estimates - Nov 13th, 2025 3:15 pm
Co-Diagnostics Reports Third Quarter 2025 Financial Results - Nov 13th, 2025 2:01 pm
Utah Governor Cox and BioUtah Recognize Co-Diagnostics Following Recent JV Announcement in Kingdom of Saudi Arabia - Nov 12th, 2025 7:00 am